Biochemical and pharmacological considerations in the development of heparin and its depolymerized derivatives
- 1 May 1986
- journal article
- research article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 144 (S1) , HS21-HS30
- https://doi.org/10.5694/j.1326-5377.1986.tb112379.x
Abstract
Click on the article title to read more.This publication has 17 references indexed in Scilit:
- Biochemical and Pharmacological Studies on the Interaction of PK 10169 and Its Subfractions with Human PlateletsPathophysiology of Haemostasis and Thrombosis, 1986
- Studies on the Profibrinolytic Actions of Heparin and Its FractionsSeminars in Thrombosis and Hemostasis, 1985
- Preliminary Biochemical and Pharmacologic Studies on a Chemically Synthesized PentasaccharideSeminars in Thrombosis and Hemostasis, 1985
- Development of Heparin Fractions: Some Overlooked ConsiderationsSeminars in Thrombosis and Hemostasis, 1985
- Heparin, Its Fractions, Fragments and Derivatives Some Newer PerspectivesSeminars in Thrombosis and Hemostasis, 1985
- Development of Fibrinopeptide A Generation Tests in the Evaluation and the Monitoring of the Action of Heparin and Its Low Molecular Weight FractionsSeminars in Thrombosis and Hemostasis, 1984
- Anticoagulant effects of two types of low molecular weight heparin administered subcutaneouslyThrombosis Research, 1983
- Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityBiochemical and Biophysical Research Communications, 1983
- Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis.BMJ, 1982
- Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtrationThrombosis Research, 1976